glp 1 in europe Oral GLP-1 Market to Rise at 35.05% CAGR till 2035 UK gives Wegovy GLP-1 pill
Description
*These statements have not been evaluated by the Food and Drug Administration
Notably, despite the positive effects on renal outcomes, the study also reported an increased incidence of gastrointestinal side effects, including nausea, vomiting, and diarrhea, though these were not statistically significant [89]
doi: 10.1111/dom.12596 94 GlaesnerWVickAMMillicanREllisBTschangSHTianYet al
We vet everything on PubMed so you dont have to
Many people experience mild digestive discomfort when first starting GLP-1 drugs, which typically improves over several weeks
